Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
ACB 
Aurora Cannabis Inc (ACB)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/15/2025: ACB (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
6 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $6.31
1 Year Target Price $6.31
| 3 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -43.61% | Avg. Invested days 27 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 286.41M USD | Price to earnings Ratio - | 1Y Target Price 6.31 |
Price to earnings Ratio - | 1Y Target Price 6.31 | ||
Volume (30-day avg) 6 | Beta 3.38 | 52 Weeks Range 3.42 - 7.05 | Updated Date 08/16/2025 |
52 Weeks Range 3.42 - 7.05 | Updated Date 08/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.04 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-08-05 | When Before Market | Estimate 0.0894 | Actual -0.27 |
Profitability
Profit Margin -5.05% | Operating Margin (TTM) -20.63% |
Management Effectiveness
Return on Assets (TTM) -0.81% | Return on Equity (TTM) -1.19% |
Valuation
Trailing PE - | Forward PE 96.15 | Enterprise Value 258282689 | Price to Sales(TTM) 0.8 |
Enterprise Value 258282689 | Price to Sales(TTM) 0.8 | ||
Enterprise Value to Revenue 0.99 | Enterprise Value to EBITDA 13.35 | Shares Outstanding 56252700 | Shares Floating 56217970 |
Shares Outstanding 56252700 | Shares Floating 56217970 | ||
Percent Insiders - | Percent Institutions 16.27 |
Upturn AI SWOT
Aurora Cannabis Inc
Company Overview
History and Background
Aurora Cannabis Inc. was founded in 2006 and is headquartered in Edmonton, Canada. Initially focused on medical cannabis, Aurora rapidly expanded through acquisitions and strategic partnerships, becoming a significant player in the global cannabis market. It faced financial challenges due to overexpansion and market volatility.
Core Business Areas
- Medical Cannabis: Aurora offers a range of medical cannabis products, including dried flowers, oils, softgels, and capsules, for patients with various medical conditions. They focus on high-quality, consistent products.
- Consumer Cannabis: Aurora sells recreational cannabis products under various brands, including dried flower, pre-rolls, vaporizers, and edibles, targeting adult-use consumers.
- International: Aurora exports medical cannabis to several international markets, including Europe, South America, and Australia, adhering to local regulations and standards.
- Cannabis 2.0 Products: Aurora offers cannabis derivative products like edibles, concentrates, and vape pens.
Leadership and Structure
The company is led by Miguel Martin (CEO). The organizational structure includes departments for cultivation, production, research & development, sales & marketing, finance, and regulatory compliance.
Top Products and Market Share
Key Offerings
- Dried Flower: Aurora offers various strains of dried cannabis flower. Market share is difficult to pinpoint exactly due to fluctuating market conditions, but Aurora is a significant player in Canada. Competitors include Canopy Growth (CGC) and Tilray (TLRY).
- Cannabis Oils: Aurora produces a range of cannabis oils for medical and recreational use. Market share varies by region. Competitors include Organigram (OGI) and Cronos Group (CRON).
- Vaporizers: Aurora sells cannabis vaporizers and vape products. Market share is less than dried flower and oils, with significant competition from other cannabis companies and specialized vape brands.
Market Dynamics
Industry Overview
The cannabis industry is characterized by rapid growth, increasing legalization, and evolving regulations. It is also highly competitive and volatile, with new entrants and changing consumer preferences.
Positioning
Aurora aims to be a leading global cannabis company with a focus on high-quality products and operational efficiency. However, it faces challenges from larger competitors with greater financial resources. Aurora is positioned as a premium brand.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars in the coming years. Aurora is attempting to capture a significant portion of this TAM through expansion into new markets and product innovation.
Upturn SWOT Analysis
Strengths
- Established brand recognition
- Advanced cultivation facilities
- Strong international presence
- Focus on medical cannabis
Weaknesses
- History of net losses
- High operating expenses
- Significant debt load
- Dilution of shares through equity financing
Opportunities
- Further legalization in key markets
- Expansion of product offerings (e.g., edibles, beverages)
- Strategic partnerships with established companies
- Growth in medical cannabis demand
Threats
- Intense competition
- Evolving regulations and compliance costs
- Price volatility
- Oversupply in certain markets
Competitors and Market Share
Key Competitors
- CGC
- TLRY
- CRON
- OGI
Competitive Landscape
Aurora faces intense competition from larger, more established cannabis companies with greater financial resources and market share. It aims to differentiate itself through product quality, brand recognition, and international presence.
Major Acquisitions
MedReleaf
- Year: 2018
- Acquisition Price (USD millions): 2640
- Strategic Rationale: To expand production capacity and market share in the Canadian cannabis market.
Growth Trajectory and Initiatives
Historical Growth: Aurora experienced rapid growth in its early years through acquisitions. However, growth has slowed in recent years due to market challenges and strategic shifts.
Future Projections: Analyst estimates for Aurora's future growth vary widely, with some expecting a rebound in revenue and others forecasting continued challenges.
Recent Initiatives: Recent initiatives include cost-cutting measures, restructuring of operations, and a renewed focus on profitability.
Summary
Aurora Cannabis is striving to regain its footing amidst strong competition and a challenging market. Its established brand and international presence offer some advantages. However, profitability and debt remain significant concerns, and a more focused, sustainable approach is needed to succeed. They need to improve market share and avoid dilution of shares.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Industry Reports
- Financial News Outlets
- Analyst Estimates
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Aurora Cannabis Inc
Exchange NASDAQ | Headquaters Edmonton, AB, Canada | ||
IPO Launch date 2014-07-11 | CEO & Executive Chairman Mr. Miguel Martin | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees - | Website https://www.auroramj.com |
Full time employees - | Website https://www.auroramj.com | ||
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally. It operates through two segments, Canadian Cannabis and Plant Propagation. The company offers pharmaceutical-grade cannabis products; medical and consumer cannabis products; and engages in the propagation of vegetables and floral plants. It also provides dried and fresh cannabis, cannabis oils, trims, concentrates, ingestibles, capsules, vaporizers, edible cannabis, cannabis extracts, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes San Rafael '71, Greybeard, Drift, Daily Special, Being, CanniMed, MedReleaf, Aurora, and WMMC, as well as international brands include Pedanios, Bidiol, IndiMed, and CraftPlant. The company was founded in 2013 and is headquartered in Edmonton, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.